Lurasidone 40 mg Improved Five PANSS Symptom Domains in Acute Schizophrenia
TL;DR: A 2026 post-hoc analysis in International Clinical Psychopharmacology found that lurasidone 40 mg/day improved all 5 Positive and Negative Syndrome Scale (PANSS) symptom domains in acute schizophrenia over 6 weeks, with the largest effect on positive symptoms and later improvement in negative symptoms. Key Findings 483 randomized patients: The JEWEL phase 3 trial assigned …
